Prescient Surgical, innovator of advanced tools and technologies to fight and defend against the sources of surgical site infection, announced that its CleanCision active cleansing technology, earned the 2018 Medical Device Excellence Award (MDEA) Bronze Medal in the ER and OR tools category. CleanCision also earned the overall MDEA Reader’s Choice Award, which spans all categories in the competition.
CleanCision is the first in a new FDA device class of irrigating wound protectors developed to retract the surgical incision, provide abdominal access, and consistently and continuously irrigate the wound edge with a surgeon-selected fluid therapy to actively fight and remove the root cause of surgical site infection – wound contamination – without disrupting current surgical practice.
Developed and designed collaboratively with surgeons and infection control experts, the first-in-class CleanCision system continuously clears harmful bacteria from surgical incisions by combining wound protection and irrigation into an intuitive and easy-to-use retraction system.
“We share this award with the surgeons and infection control experts who collaborated with us to create an intuitive design that is filling a critical gap in hospital surgical site infection control programs,” said Jonathan Coe, president, CEO and co-founder of Prescient Surgical.